» Articles » PMID: 20807839

A High-fat, Ketogenic Diet Causes Hepatic Insulin Resistance in Mice, Despite Increasing Energy Expenditure and Preventing Weight Gain

Overview
Date 2010 Sep 3
PMID 20807839
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

Low-carbohydrate, high-fat ketogenic diets (KD) have been suggested to be more effective in promoting weight loss than conventional caloric restriction, whereas their effect on hepatic glucose and lipid metabolism and the mechanisms by which they may promote weight loss remain controversial. The aim of this study was to explore the role of KD on liver and muscle insulin sensitivity, hepatic lipid metabolism, energy expenditure, and food intake. Using hyperinsulinemic-euglycemic clamps, we studied insulin action in mice fed a KD or regular chow (RC). Body composition was assessed by ¹H magnetic resonance spectroscopy. Despite being 15% lighter (P < 0.001) than RC-fed mice because of a 17% increase in energy expenditure (P < 0.001), KD-fed mice manifested severe hepatic insulin resistance, as reflected by decreased suppression (0% vs. 100% in RC-fed mice, P < 0.01) of endogenous glucose production during the clamp. Hepatic insulin resistance could be attributed to a 350% increase in hepatic diacylglycerol content (P < 0.001), resulting in increased activation of PKCε (P < 0.05) and decreased insulin receptor substrate-2 tyrosine phosphorylation (P < 0.01). Food intake was 56% (P < 0.001) lower in KD-fed mice, despite similar caloric intake, and could partly be attributed to a more than threefold increase (P < 0.05) in plasma N-acylphosphatidylethanolamine concentrations. In conclusion, despite preventing weight gain in mice, KD induces hepatic insulin resistance secondary to increased hepatic diacylglycerol content. Given the key role of nonalcoholic fatty liver disease in the development of type 2 diabetes and the widespread use of KD for the treatment of obesity, these results may have potentially important clinical implications.

Citing Articles

Macronutrient Modulation in Metabolic Dysfunction-Associated Steatotic Liver Disease-the Molecular Role of Fatty Acids compared with Sugars in Human Metabolism and Disease Progression.

Mullin S, Kelly A, Ni Chathail M, Norris S, Shannon C, Roche H Adv Nutr. 2025; 16(3):100375.

PMID: 39842721 PMC: 11849631. DOI: 10.1016/j.advnut.2025.100375.


The gut microbiota changed by ketogenic diets contribute to glucose intolerance rather than lipid accumulation.

Li W, Gong M, Wang Z, Pan H, Li Y, Zhang C Front Endocrinol (Lausanne). 2024; 15:1446287.

PMID: 39398341 PMC: 11466860. DOI: 10.3389/fendo.2024.1446287.


The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischaemic heart failure.

Ho K, Karwi Q, Wang F, Wagg C, Zhang L, Panidarapu S Cardiovasc Res. 2024; 120(10):1126-1137.

PMID: 38691671 PMC: 11368127. DOI: 10.1093/cvr/cvae092.


Genetics and diet shape the relationship between islet function and whole body metabolism.

Yau B, Madsen S, Nelson M, Cooke K, Fritzen A, Thorius I Am J Physiol Endocrinol Metab. 2024; 326(5):E663-E672.

PMID: 38568150 PMC: 11376487. DOI: 10.1152/ajpendo.00060.2024.


The Ketone Bridge Between the Heart and the Bladder: How Fast Should We Go?.

Faria-Costa G, Oliveira J, Vilas-Boas I, Campelo I, Silva E, Bras-Silva C Int Neurourol J. 2024; 28(Suppl 1):2-11.

PMID: 38461852 PMC: 10932574. DOI: 10.5213/inj.2346250.125.


References
1.
Feldmann H, Golozoubova V, Cannon B, Nedergaard J . UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 2009; 9(2):203-9. DOI: 10.1016/j.cmet.2008.12.014. View

2.
Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V . Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007; 5(6):415-25. DOI: 10.1016/j.cmet.2007.05.003. View

3.
Samuel V, Choi C, Phillips T, Romanelli A, Geisler J, Bhanot S . Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes. 2006; 55(7):2042-50. DOI: 10.2337/db05-0705. View

4.
Choi C, Savage D, Kulkarni A, Yu X, Liu Z, Morino K . Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J Biol Chem. 2007; 282(31):22678-88. DOI: 10.1074/jbc.M704213200. View

5.
Brinkworth G, Noakes M, Buckley J, Keogh J, Clifton P . Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr. 2009; 90(1):23-32. DOI: 10.3945/ajcn.2008.27326. View